Literature DB >> 19666559

Variations in the colchicine-binding domain provide insight into the structural switch of tubulin.

Audrey Dorléans1, Benoît Gigant, Raimond B G Ravelli, Patrick Mailliet, Vincent Mikol, Marcel Knossow.   

Abstract

Structural changes occur in the alphabeta-tubulin heterodimer during the microtubule assembly/disassembly cycle. Their most prominent feature is a transition from a straight, microtubular structure to a curved structure. There is a broad range of small molecule compounds that disturbs the microtubule cycle, a class of which targets the colchicine-binding site and prevents microtubule assembly. This class includes compounds with very different chemical structures, and it is presently unknown whether they prevent tubulin polymerization by the same mechanism. To address this issue, we have determined the structures of tubulin complexed with a set of such ligands and show that they interfere with several of the movements of tubulin subunits structural elements upon its transition from curved to straight. We also determined the structure of tubulin unliganded at the colchicine site; this reveals that a beta-tubulin loop (termed T7) flips into this site. As with colchicine site ligands, this prevents a helix which is at the interface with alpha-tubulin from stacking onto a beta-tubulin beta sheet as in straight protofilaments. Whereas in the presence of these ligands the interference with microtubule assembly gets frozen, by flipping in and out the beta-subunit T7 loop participates in a reversible way in the resistance to straightening that opposes microtubule assembly. Our results suggest that it thereby contributes to microtubule dynamic instability.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19666559      PMCID: PMC2728970          DOI: 10.1073/pnas.0904223106

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  35 in total

1.  The 4 A X-ray structure of a tubulin:stathmin-like domain complex.

Authors:  B Gigant; P A Curmi; C Martin-Barbey; E Charbaut; S Lachkar; L Lebeau; S Siavoshian; A Sobel; M Knossow
Journal:  Cell       Date:  2000-09-15       Impact factor: 41.582

2.  Microtubule structure at 8 A resolution.

Authors:  Huilin Li; David J DeRosier; William V Nicholson; Eva Nogales; Kenneth H Downing
Journal:  Structure       Date:  2002-10       Impact factor: 5.006

3.  PRODRG: a tool for high-throughput crystallography of protein-ligand complexes.

Authors:  Alexander W Schüttelkopf; Daan M F van Aalten
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2004-07-21

4.  Insight into tubulin regulation from a complex with colchicine and a stathmin-like domain.

Authors:  Raimond B G Ravelli; Benoît Gigant; Patrick A Curmi; Isabelle Jourdain; Sylvie Lachkar; André Sobel; Marcel Knossow
Journal:  Nature       Date:  2004-03-11       Impact factor: 49.962

5.  An extensively modified version of MolScript that includes greatly enhanced coloring capabilities.

Authors:  R M Esnouf
Journal:  J Mol Graph Model       Date:  1997-04       Impact factor: 2.518

6.  Response of microtubules to the addition of colchicine and tubulin-colchicine: evaluation of models for the interaction of drugs with microtubules.

Authors:  A Vandecandelaere; S R Martin; Y Engelborghs
Journal:  Biochem J       Date:  1997-04-01       Impact factor: 3.857

7.  Mechanism of action of E7010, an orally active sulfonamide antitumor agent: inhibition of mitosis by binding to the colchicine site of tubulin.

Authors:  K Yoshimatsu; A Yamaguchi; H Yoshino; N Koyanagi; K Kitoh
Journal:  Cancer Res       Date:  1997-08-01       Impact factor: 12.701

8.  Phosphate release during microtubule assembly: what stabilizes growing microtubules?

Authors:  A Vandecandelaere; M Brune; M R Webb; S R Martin; P M Bayley
Journal:  Biochemistry       Date:  1999-06-22       Impact factor: 3.162

9.  Selective, covalent modification of beta-tubulin residue Cys-239 by T138067, an antitumor agent with in vivo efficacy against multidrug-resistant tumors.

Authors:  B Shan; J C Medina; E Santha; W P Frankmoelle; T C Chou; R M Learned; M R Narbut; D Stott; P Wu; J C Jaen; T Rosen; P B Timmermans; H Beckmann
Journal:  Proc Natl Acad Sci U S A       Date:  1999-05-11       Impact factor: 11.205

10.  Synthesis, biodistribution and micro-PET imaging of radiolabeled antimitotic agent T138067 analogues.

Authors:  Xiangshu Fei; Qi-Huang Zheng; Ji-Quan Wang; K Lee Stone; Tanya D Martinez; Kathy D Miller; George W Sledge; Gary D Hutchins
Journal:  Bioorg Med Chem Lett       Date:  2004-03-08       Impact factor: 2.823

View more
  66 in total

1.  Mapping flexibility and the assembly switch of cell division protein FtsZ by computational and mutational approaches.

Authors:  Antonio J Martín-Galiano; Rubén M Buey; Marta Cabezas; José M Andreu
Journal:  J Biol Chem       Date:  2010-05-13       Impact factor: 5.157

2.  Pyrrole-Based Antitubulin Agents: Two Distinct Binding Modalities are Predicted for C-2 Analogs in the Colchicine Site.

Authors:  Chenxiao Da; Nakul Telang; Peter Barelli; Xin Jia; John T Gupton; Susan L Mooberry; Glen E Kellogg
Journal:  ACS Med Chem Lett       Date:  2011-11-01       Impact factor: 4.345

3.  Design, synthesis and biological evaluation of 3,5-disubstituted 2-amino thiophene derivatives as a novel class of antitumor agents.

Authors:  Romeo Romagnoli; Pier Giovanni Baraldi; Carlota Lopez-Cara; Maria Kimatrai Salvador; Delia Preti; Mojgan Aghazadeh Tabrizi; Jan Balzarini; Peter Nussbaumer; Marcella Bassetto; Andrea Brancale; Xian-Hua Fu; Jun Li; Su-Zhan Zhang; Ernest Hamel; Roberta Bortolozzi; Giuseppe Basso; Giampietro Viola
Journal:  Bioorg Med Chem       Date:  2013-12-24       Impact factor: 3.641

4.  Heterocyclic-Fused Pyrimidines as Novel Tubulin Polymerization Inhibitors Targeting the Colchicine Binding Site: Structural Basis and Antitumor Efficacy.

Authors:  Souvik Banerjee; Kinsie E Arnst; Yuxi Wang; Gyanendra Kumar; Shanshan Deng; Lei Yang; Guo-Bo Li; Jinliang Yang; Stephen W White; Wei Li; Duane D Miller
Journal:  J Med Chem       Date:  2018-02-12       Impact factor: 7.446

5.  Structures of potent anticancer compounds bound to tubulin.

Authors:  Dan E McNamara; Silvia Senese; Todd O Yeates; Jorge Z Torres
Journal:  Protein Sci       Date:  2015-05-27       Impact factor: 6.725

6.  Stathmin and interfacial microtubule inhibitors recognize a naturally curved conformation of tubulin dimers.

Authors:  Pascale Barbier; Audrey Dorléans; Francois Devred; Laura Sanz; Diane Allegro; Carlos Alfonso; Marcel Knossow; Vincent Peyrot; Jose M Andreu
Journal:  J Biol Chem       Date:  2010-07-30       Impact factor: 5.157

7.  Novel CIL-102 derivatives as potential therapeutic agents for docetaxel-resistant prostate cancer.

Authors:  Dannah R Miller; Cherng-Chyi Tzeng; Trey Farmer; Evan T Keller; Steve Caplan; Yu-Shuin Chen; Yeh-Long Chen; Ming-Fong Lin
Journal:  Cancer Lett       Date:  2018-08-03       Impact factor: 8.679

8.  Developing novel C-4 analogues of pyrrole-based antitubulin agents: weak but critical hydrogen bonding in the colchicine site.

Authors:  Chenxiao Da; Nakul Telang; Kayleigh Hall; Emily Kluball; Peter Barelli; Kara Finzel; Xin Jia; John T Gupton; Susan L Mooberry; Glen E Kellogg
Journal:  Medchemcomm       Date:  2013       Impact factor: 3.597

9.  Biological Characterization of an Improved Pyrrole-Based Colchicine Site Agent Identified through Structure-Based Design.

Authors:  Cristina C Rohena; Nakul S Telang; Chenxiao Da; April L Risinger; James A Sikorski; Glen E Kellogg; John T Gupton; Susan L Mooberry
Journal:  Mol Pharmacol       Date:  2015-12-11       Impact factor: 4.436

10.  Direct modulation of microtubule stability contributes to anthracene general anesthesia.

Authors:  Daniel J Emerson; Brian P Weiser; John Psonis; Zhengzheng Liao; Olena Taratula; Ashley Fiamengo; Xiaozhao Wang; Keizo Sugasawa; Amos B Smith; Roderic G Eckenhoff; Ivan J Dmochowski
Journal:  J Am Chem Soc       Date:  2013-03-29       Impact factor: 15.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.